This agent is marketed alone (NESINA), or combined with metformin (KAZANO), or with pioglitazone (OSENI). Alogliptin has been studied as monotherapy in 8,500 individuals with diabetes in a total ...

Ramadan is a blessed month in the Muslim calendar. It is obligatory for Muslims to observe fast this month. Every year, I ...

Metformin is the most commonly prescribed drug used for the treatment of type 2 diabetes. Even so, not everyone responds to metformin in the same way, and, over time, the drug can start to lose its ...

Genetic risk scores for predicting insulin resistance that were developed for adults are also tied to some cardiometabolic metrics in children and adolescents, according to study findings. Among ...

Objective: Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either ...

The rising trend in health and lifestyle related problems in the world warrants us to be well informed and health-conscious of the latest happenings in this field. Medindia offers a freely ...